Kirin (OTCMKTS:KNBWY) Posts Earnings Results, Beats Estimates By $0.09 EPS

Kirin (OTCMKTS:KNBWY) announced its quarterly earnings results on Wednesday. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.27 by $0.09, Zacks reports. Kirin had a net margin of 7.79% and a return on equity of 12.22%.

Kirin Stock Performance

Shares of KNBWY traded down $0.63 during mid-day trading on Wednesday, reaching $18.66. 30,730 shares of the company’s stock were exchanged, compared to its average volume of 28,601. The business’s fifty day simple moving average is $18.40 and its 200-day simple moving average is $17.36. The stock has a market capitalization of $15.12 billion, a PE ratio of 11.89 and a beta of 0.05. Kirin has a 52-week low of $14.66 and a 52-week high of $20.21. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.48 and a quick ratio of 1.02.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Kirin from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 29th. One research analyst has rated the stock with a Hold rating. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold”.

About Kirin

Kirin Holdings Company, Limited is a Japanese company with businesses in beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks and other nonalcoholic products, with brands sold in Japan and international markets. The company traces its roots to the Japan Brewery Company, established in 1885, and adopted the Kirin Brewery name in 1907. Today, its pharmaceutical business includes Kyowa Kirin, which develops and sells medicines, while its health science activities include products such as supplements and functional foods.